Clover Biopharmaceuticals, Ltd. (Clover) announced the appointment of Mr. LiongHo Chua as President of Greater China. Mr. Chua will report to the Company's Chief Executive Officer and Executive Director, Joshua Liang. Prior to joining Clover, Mr. Chua served as the Executive President and Chief Strategy Officer for AIM Vaccine.

Before AIM Vaccine, he held the position of Country Manager for Sandoz China, a leader in generic and biosimilar pharmaceuticals, where he successfully implemented a market access strategy for its portfolio of products.